Results 201 to 210 of about 386,285 (319)

The efficacy of immunotherapy combined with capecitabine versus immunotherapy alone as maintenance therapy in patients with de novo metastatic nasopharyngeal carcinoma: a retrospective propensity score matching study. [PDF]

ESMO Open
He SQ, Lv SH, Wen SQ, Wang L, Zhao ZY, Bei WX, Huang Y, Xiang YQ, Liu GY.   +8 more
europepmc   +1 more source

Tumor–Stroma Ratio in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis

Oral Diseases, EarlyView.
ABSTRACT Background Tumor‐stroma ratio (TSR) has been recognized as a significant prognostic factor in various cancers. This systematic review evaluates the role of TSR in head and neck squamous cell carcinoma (HNSCC) and its association with patient outcomes such as overall survival (OS), disease‐free survival (DFS), disease‐specific survival (DSS ...
Gennaro Musella, Martina Coppini, Fábio França Vieira E Silva, Giuseppina Campisi, Mario Pérez‐Sayáns, Vito Carlo Alberto Caponio, Alejandro I. Lorenzo‐Pouso   +6 more
wiley   +1 more source

Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens. [PDF]

BMC Cancer
Li XQ, Lin DF, Cai YC, Xie SH, Lin KN, Zhou HN, Wu ZC, Ye JP, Peng YN, Ma Z, Guo L, Lin W, Cao SM.   +12 more
europepmc   +1 more source

Effects of Public Disclosure of a Japanese Celebrity's Oral Cancer: Trends in Oral Cancer Diagnoses

Oral Diseases, EarlyView.
ABSTRACT Objective On February 19, 2019, Chiemi Hori, a renowned Japanese singer, publicly announced her diagnosis of stage IV tongue cancer. The news was widely reported by the Japanese media. This study examined the association between the celebrity's tongue cancer disclosure and trends in the number of oral cancer diagnoses in the national ...
Shihoko Koyama, Takahiro Tabuchi, Kayo Nakata, Toshitaka Morishima, Shuji Uchida, Miki Ishibashi, Isao Miyashiro   +6 more
wiley   +1 more source

The role of radiotherapy in distant nasopharyngeal carcinoma: a SEER analysis. [PDF]

Transl Cancer Res
Chen L, Mo DC, He JN, Du KJ, Peng LP, Yin SH.   +5 more
europepmc   +1 more source

Role of Cancer Associated Fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review. [PDF]

BMC Cancer
Golestannejad P, Monkaresi M, Zhian Zargaran F, Khosravani M, Asgari P, Mobaraki H, Gorjizad M, Hasany S, Senobari Ghezeljehmeidan A, Hemmati S, Zand S, Ghasemi P, Asadi Anar M.   +12 more
europepmc   +1 more source

Design of a Novel Artificial Atlanto‐Odontoid Joint and Its Anatomical and Radiological Studies Following Transoral Pharyngeal Approach Arthroplasty

Orthopaedic Surgery, EarlyView.
The implantation of the novel artificial atlanto‐odontoid joint (AAOJ) is both safe and convenient, and it preserves the normal range of rotational, flexion‐extension, and lateral bending motion between the atlas and axis. ABSTRACT Objective For atlantoaxial joint disorders, traditional surgical approaches often presented challenges such as significant
Shengguang Lei, Lingyong Jing, Xijiong Chen, Zhiwei Gan, Jianbin Zhong, Liming Yu, Yong Hu   +6 more
wiley   +1 more source

The adverse events of toripalimab in nasopharyngeal carcinoma based on FAERS database and bibliometric analysis. [PDF]

PLoS One
Guo Q, Dong D, Dang Z, Huang S, Qiao X, Zhang B, Zhao Y.   +6 more
europepmc   +1 more source

The Landscape of Cancer Metabolism as a Therapeutic Target

Pathology International, EarlyView.
ABSTRACT Cancer cells reprogram their metabolism during progression to adapt to the tumor microenvironment, which is characterized by distinct differences in nutrient availability, oxygen concentrations, and acidity. This metabolic reprogramming can simultaneously create metabolic vulnerabilities unique to cancer cells, making cancer metabolism a ...
Kenji Ohshima
wiley   +1 more source

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study. [PDF]

Cancer Immunol Immunother
Lai M, Li S, Jin Z, Chang M, Li F, Yang P, He Y, Zhang Q.   +7 more
europepmc   +1 more source